Cordis appeals $40M award to Boston Sci

Patent disputes involving big names can involve big settlements. And a decision in favor of Boston Scientific ($BSX) over Johnson & Johnson ($JNJ) unit Cordis is no exception. Natick, MA-based Boston Sci scored a cool $40 million ruling last month in its favor against Cordis--twice what a jury awarded it in May 2011. But Cordis has filed an appeal with the U.S. Court of Appeals for the Federal Circuit in Washington. Item


Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.